Personalised Care for Type Two Diabetes (T2D)

A personalised approach to achieving target glucose levels via a shared clinical decision support tool

Nearly 10% of deaths in Australia are because of diabetes, mostly type 2 diabetes (T2D). Keeping glucose levels in target range is a key strategy in reducing death and complications from T2D.

Getting glucose levels to target is a challenge for people with T2D and for their health professionals (eg GPs, Diabetes Educators, Endocrinologists). T2D is a progressive condition so achieving target glucose levels involve supporting patients’ self-management, as well as intensifying medical treatment in a stepwise, evidence-based way. This is further complicated by the increasing number of new treatment options available that address glucose levels. The solution is personalised treatment tailored to the individual: the characteristics of their diabetes (e.g. duration, current medications), other conditions (e.g. kidney and liver function) as well as the person’s own preferences, resources, and supports.

This project is exploring the clinical reasoning that clinicians and patients use when personalising glucose targets and treatments to develop a prototype clinical decision support tool based on algorithms developed from this clinical reasoning. The prototype will form the basis of a configurable, generic application for multiple health conditions that can be incrementally developed and deployed in general practice and related sectors.

Research Team


Seed Funding 2017